115 related articles for article (PubMed ID: 26286058)
1. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging.
Das GK; Johnson NJ; Cramen J; Blasiak B; Latta P; Tomanek B; van Veggel FC
J Phys Chem Lett; 2012 Feb; 3(4):524-9. PubMed ID: 26286058
[TBL] [Abstract][Full Text] [Related]
2. Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometry.
Bulte JW; Wu C; Brechbiel MW; Brooks RA; Vymazal J; Holla M; Frank JA
Invest Radiol; 1998 Nov; 33(11):841-5. PubMed ID: 9818319
[TBL] [Abstract][Full Text] [Related]
3. New Class of Efficient T
Yue H; Park JA; Ho SL; Ahmad MY; Cha H; Liu S; Tegafaw T; Marasini S; Ghazanfari A; Kim S; Chae KS; Chang Y; Lee GH
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33076332
[TBL] [Abstract][Full Text] [Related]
4. Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: synthesis, characterization, and in vivo application.
Tegafaw T; Xu W; Ahmad MW; Baeck JS; Chang Y; Bae JE; Chae KS; Kim TJ; Lee GH
Nanotechnology; 2015 Sep; 26(36):365102. PubMed ID: 26291827
[TBL] [Abstract][Full Text] [Related]
5. Target-Specific Magnetic Resonance Imaging of Human Prostate Adenocarcinoma Using NaDyF
Dash A; Blasiak B; Tomanek B; Latta P; van Veggel FCJM
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24345-24355. PubMed ID: 34024098
[TBL] [Abstract][Full Text] [Related]
6. Nuclear magnetic resonance relaxivities: investigations of ultrahigh-spin lanthanide clusters from 10 MHz to 1.4 GHz.
Machado JR; Baniodeh A; Powell AK; Luy B; Krämer S; Guthausen G
Chemphyschem; 2014 Nov; 15(16):3608-13. PubMed ID: 25115895
[TBL] [Abstract][Full Text] [Related]
7. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent.
Norek M; Kampert E; Zeitler U; Peters JA
J Am Chem Soc; 2008 Apr; 130(15):5335-40. PubMed ID: 18355014
[TBL] [Abstract][Full Text] [Related]
8. Holmium phosphate nanoparticles as negative contrast agents for high-field magnetic resonance imaging: Synthesis, magnetic relaxivity study and in vivo evaluation.
Gómez-González E; Caro C; Martínez-Gutiérrez D; García-Martín ML; Ocaña M; Becerro AI
J Colloid Interface Sci; 2021 Apr; 587():131-140. PubMed ID: 33360885
[TBL] [Abstract][Full Text] [Related]
9. Core-multi-shell design: unlocking multimodal capabilities in lanthanide-based nanoparticles as upconverting,
Liu N; Homann C; Morfin S; Kesanakurti MS; Calvert ND; Shuhendler AJ; Al T; Hemmer E
Nanoscale; 2023 Dec; 15(48):19546-19556. PubMed ID: 37982139
[TBL] [Abstract][Full Text] [Related]
10. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
[TBL] [Abstract][Full Text] [Related]
11. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
12. NMR Relaxivities of Paramagnetic Lanthanide-Containing Polyoxometalates.
Venu AC; Nasser Din R; Rudszuck T; Picchetti P; Chakraborty P; Powell AK; Krämer S; Guthausen G; Ibrahim M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946561
[TBL] [Abstract][Full Text] [Related]
13. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis.
Balachandran YL; Wang W; Yang H; Tong H; Wang L; Liu F; Chen H; Zhong K; Liu Y; Jiang X
ACS Nano; 2022 Apr; 16(4):5647-5659. PubMed ID: 35312295
[TBL] [Abstract][Full Text] [Related]
15. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
[TBL] [Abstract][Full Text] [Related]
16. A Magnetic Chameleon: Biocompatible Lanthanide Fluoride Nanoparticles with Magnetic Field Dependent Tunable Contrast Properties as a Versatile Contrast Agent for Low to Ultrahigh Field MRI and Optical Imaging in Biological Window.
Biju S; Gallo J; Bañobre-López M; Manshian BB; Soenen SJ; Himmelreich U; Vander Elst L; Parac-Vogt TN
Chemistry; 2018 May; 24(29):7388-7397. PubMed ID: 29575427
[TBL] [Abstract][Full Text] [Related]
17. Contrast visibility for indirect MR arthrography with different protein contents and agent relaxivities at different field strengths: an in vitro model.
Nouh MR; Schweitzer ME; Ragatte RR
Eur J Radiol; 2011 Nov; 80(2):559-64. PubMed ID: 21242041
[TBL] [Abstract][Full Text] [Related]
18. Dy-DTPA derivatives as relaxation agents for very high field MRI: the beneficial effect of slow water exchange on the transverse relaxivities.
Vander Elst L; Roch A; Gillis P; Laurent S; Botteman F; Bulte JW; Muller RN
Magn Reson Med; 2002 Jun; 47(6):1121-30. PubMed ID: 12111958
[TBL] [Abstract][Full Text] [Related]
19. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.
Rohrer M; Bauer H; Mintorovitch J; Requardt M; Weinmann HJ
Invest Radiol; 2005 Nov; 40(11):715-24. PubMed ID: 16230904
[TBL] [Abstract][Full Text] [Related]
20. Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.
Hu H; Zhang Y; Shukla S; Gu Y; Yu X; Steinmetz NF
ACS Nano; 2017 Sep; 11(9):9249-9258. PubMed ID: 28858475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
